Global Infant Probiotics Market Growth 2024-2030

Publication ID:

LPI05248403

Publication Date:

May 29, 2024

Pages:

119

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Probiotics are a class of active microorganisms that are beneficial to the host by colonizing the human body and changing the composition of the flora in a certain part of the host. By regulating the immune function of the host mucosa and system or by regulating the balance of intestinal flora, promoting nutrient absorption and maintaining intestinal health, resulting in the production of single microorganisms or mixed microorganisms with a clear composition that are beneficial to health
The global Infant Probiotics market size is projected to grow from US$ 719.3 million in 2023 to US$ 978.3 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.
The 鈥淚nfant Probiotics Industry Forecast鈥� looks at past sales and reviews total world Infant Probiotics sales in 2023, providing a comprehensive analysis by region and market sector of projected Infant Probiotics sales for 2024 through 2030. With Infant Probiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infant Probiotics industry.
This Insight Report provides a comprehensive analysis of the global Infant Probiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infant Probiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Infant Probiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infant Probiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infant Probiotics.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is 楼17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is 楼485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
This report presents a comprehensive overview, market shares, and growth opportunities of Infant Probiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Probiotic Powder
Probiotic Drops
Probiotic Capsules
Segmentation by application
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Contrale
BioGaia AB
Nutrition Care
Synbiotics
Natural Factors
NOVA Probiotics
Jarrow Formulas
Life-Space
The Clorox Company
DR. WILLMAR SCHWABE GROUP
Church & Dwight
Swanson
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infant Probiotics market?
What factors are driving Infant Probiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infant Probiotics market opportunities vary by end market size?
How does Infant Probiotics break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infant Probiotics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Infant Probiotics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Infant Probiotics by Country/Region, 2019, 2023 & 2030
2.2 Infant Probiotics Segment by Type
2.2.1 Probiotic Powder
2.2.2 Probiotic Drops
2.2.3 Probiotic Capsules
2.3 Infant Probiotics Sales by Type
2.3.1 Global Infant Probiotics Sales Market Share by Type (2019-2024)
2.3.2 Global Infant Probiotics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Infant Probiotics Sale Price by Type (2019-2024)
2.4 Infant Probiotics Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Infant Probiotics Sales by Application
2.5.1 Global Infant Probiotics Sale Market Share by Application (2019-2024)
2.5.2 Global Infant Probiotics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Infant Probiotics Sale Price by Application (2019-2024)
3 Global Infant Probiotics by Company
3.1 Global Infant Probiotics Breakdown Data by Company
3.1.1 Global Infant Probiotics Annual Sales by Company (2019-2024)
3.1.2 Global Infant Probiotics Sales Market Share by Company (2019-2024)
3.2 Global Infant Probiotics Annual Revenue by Company (2019-2024)
3.2.1 Global Infant Probiotics Revenue by Company (2019-2024)
3.2.2 Global Infant Probiotics Revenue Market Share by Company (2019-2024)
3.3 Global Infant Probiotics Sale Price by Company
3.4 Key Manufacturers Infant Probiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infant Probiotics Product Location Distribution
3.4.2 Players Infant Probiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Infant Probiotics by Geographic Region
4.1 World Historic Infant Probiotics Market Size by Geographic Region (2019-2024)
4.1.1 Global Infant Probiotics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Infant Probiotics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Infant Probiotics Market Size by Country/Region (2019-2024)
4.2.1 Global Infant Probiotics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Infant Probiotics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Infant Probiotics Sales Growth
4.4 APAC Infant Probiotics Sales Growth
4.5 Europe Infant Probiotics Sales Growth
4.6 Middle East & Africa Infant Probiotics Sales Growth
5 Americas
5.1 Americas Infant Probiotics Sales by Country
5.1.1 Americas Infant Probiotics Sales by Country (2019-2024)
5.1.2 Americas Infant Probiotics Revenue by Country (2019-2024)
5.2 Americas Infant Probiotics Sales by Type
5.3 Americas Infant Probiotics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infant Probiotics Sales by Region
6.1.1 APAC Infant Probiotics Sales by Region (2019-2024)
6.1.2 APAC Infant Probiotics Revenue by Region (2019-2024)
6.2 APAC Infant Probiotics Sales by Type
6.3 APAC Infant Probiotics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Infant Probiotics by Country
7.1.1 Europe Infant Probiotics Sales by Country (2019-2024)
7.1.2 Europe Infant Probiotics Revenue by Country (2019-2024)
7.2 Europe Infant Probiotics Sales by Type
7.3 Europe Infant Probiotics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infant Probiotics by Country
8.1.1 Middle East & Africa Infant Probiotics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Infant Probiotics Revenue by Country (2019-2024)
8.2 Middle East & Africa Infant Probiotics Sales by Type
8.3 Middle East & Africa Infant Probiotics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infant Probiotics
10.3 Manufacturing Process Analysis of Infant Probiotics
10.4 Industry Chain Structure of Infant Probiotics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infant Probiotics Distributors
11.3 Infant Probiotics Customer
12 World Forecast Review for Infant Probiotics by Geographic Region
12.1 Global Infant Probiotics Market Size Forecast by Region
12.1.1 Global Infant Probiotics Forecast by Region (2025-2030)
12.1.2 Global Infant Probiotics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Infant Probiotics Forecast by Type
12.7 Global Infant Probiotics Forecast by Application
13 Key Players Analysis
13.1 Contrale
13.1.1 Contrale Company Information
13.1.2 Contrale Infant Probiotics Product Portfolios and Specifications
13.1.3 Contrale Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Contrale Main Business Overview
13.1.5 Contrale Latest Developments
13.2 BioGaia AB
13.2.1 BioGaia AB Company Information
13.2.2 BioGaia AB Infant Probiotics Product Portfolios and Specifications
13.2.3 BioGaia AB Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BioGaia AB Main Business Overview
13.2.5 BioGaia AB Latest Developments
13.3 Nutrition Care
13.3.1 Nutrition Care Company Information
13.3.2 Nutrition Care Infant Probiotics Product Portfolios and Specifications
13.3.3 Nutrition Care Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Nutrition Care Main Business Overview
13.3.5 Nutrition Care Latest Developments
13.4 Synbiotics
13.4.1 Synbiotics Company Information
13.4.2 Synbiotics Infant Probiotics Product Portfolios and Specifications
13.4.3 Synbiotics Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Synbiotics Main Business Overview
13.4.5 Synbiotics Latest Developments
13.5 Natural Factors
13.5.1 Natural Factors Company Information
13.5.2 Natural Factors Infant Probiotics Product Portfolios and Specifications
13.5.3 Natural Factors Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Natural Factors Main Business Overview
13.5.5 Natural Factors Latest Developments
13.6 NOVA Probiotics
13.6.1 NOVA Probiotics Company Information
13.6.2 NOVA Probiotics Infant Probiotics Product Portfolios and Specifications
13.6.3 NOVA Probiotics Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 NOVA Probiotics Main Business Overview
13.6.5 NOVA Probiotics Latest Developments
13.7 Jarrow Formulas
13.7.1 Jarrow Formulas Company Information
13.7.2 Jarrow Formulas Infant Probiotics Product Portfolios and Specifications
13.7.3 Jarrow Formulas Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Jarrow Formulas Main Business Overview
13.7.5 Jarrow Formulas Latest Developments
13.8 Life-Space
13.8.1 Life-Space Company Information
13.8.2 Life-Space Infant Probiotics Product Portfolios and Specifications
13.8.3 Life-Space Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Life-Space Main Business Overview
13.8.5 Life-Space Latest Developments
13.9 The Clorox Company
13.9.1 The Clorox Company Company Information
13.9.2 The Clorox Company Infant Probiotics Product Portfolios and Specifications
13.9.3 The Clorox Company Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 The Clorox Company Main Business Overview
13.9.5 The Clorox Company Latest Developments
13.10 DR. WILLMAR SCHWABE GROUP
13.10.1 DR. WILLMAR SCHWABE GROUP Company Information
13.10.2 DR. WILLMAR SCHWABE GROUP Infant Probiotics Product Portfolios and Specifications
13.10.3 DR. WILLMAR SCHWABE GROUP Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 DR. WILLMAR SCHWABE GROUP Main Business Overview
13.10.5 DR. WILLMAR SCHWABE GROUP Latest Developments
13.11 Church & Dwight
13.11.1 Church & Dwight Company Information
13.11.2 Church & Dwight Infant Probiotics Product Portfolios and Specifications
13.11.3 Church & Dwight Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Church & Dwight Main Business Overview
13.11.5 Church & Dwight Latest Developments
13.12 Swanson
13.12.1 Swanson Company Information
13.12.2 Swanson Infant Probiotics Product Portfolios and Specifications
13.12.3 Swanson Infant Probiotics Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Swanson Main Business Overview
13.12.5 Swanson Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂